Antithrombin gamma
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00938288)
Timeline
Indications
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- kw-3357
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01384409 | Phase 3 | Feb 1, 2012 | Kyowa Hakko Kirin |
| NCT01384396 | Phase 3 | Dec 1, 2011 | Kyowa Hakko Kirin |
| NCT01384903 | Phase 3 | Jun 1, 2011 | Kyowa Hakko Kirin |
| NCT00938288 | Phase 1 | Apr 1, 2009 | Kyowa Hakko Kirin, University of London |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kyowa Hakko Kirin | For profit | 4 | 4 | 2 | 2009 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1